Published: Test-retest reliability of the FitMáx©-questionnaire in a clinical and healthy population
- Publication status: Published
- Type of study: Clinimetrics
- Journal: Springer Open - Journal of Patient-Reported Outcomes
- Affiliations: Eindhoven University of Technology, Maastricht University, Máxima Medical Centre
- Population: Healthy Subjects, Oncology, Cardiac, Pulmonary
- DOI: https://doi.org/10.1186/s41687-023-00682-9
- PMID: 35411174
- BibTex:
@article{Meijer2024FitMax, author = {Renske Meijer and Goof Schep and Marta Regis and Nicole E. Papen-Botterhuis and Hans H. C. M. Savelberg and Martijn van Hooff}, title = {Test–retest reliability of the FitMáx©-questionnaire in a clinical and healthy population}, journal = {Journal of Patient-Reported Outcomes}, volume = {8}, pages = {Article number: 3}, year = {2024}, doi = {10.1186/s41687-023-00682-9}, url = {https://jpro.springeropen.com/articles/10.1186/s41687-023-00682-9} }
Purpose: The FitMáx© was developed as a questionnaire-based instrument to estimate Cardiorespiratory Fitness (CRF) expressed as oxygen uptake at peak exercise (VO2peak). Test-retest reliability is a clinometric measurement property, which defines stability over time if multiple measurements are performed (i.e. reliability). The present study aimed to assess the test-retest reliability of the FitMáx©-questionnaire in different patient groups.
Patients and methods: A total of 127 cardiac, pulmonary and oncology patients and healthy subjects aged 19-84 years who completed the questionnaire twice within an average of 18 days were included for analysis. Participants were in a stable clinical situation (no acute disease or participating in a training program). To determine the test-retest reliability, the Intraclass Correlation Coefficient (ICC) and Standard Error of the Measurement (SEM) was calculated between the first (T0) and second (T1) administration of the questionnaires.
Results: An excellent agreement was found between the FitMáx©-questionnaire scores at T0 and T1, with an ICC of 0.97 (SEM 1.91) in the total study population and an ICC ranging from 0.93 to 0.98 (SEM 1.52-2.27) in the individual patient groups.
Conclusion: The FitMáx©-questionnaire proves to be reliable and stable over time to estimate CRF of patients and healthy subjects. Trial registration NTR (Netherlands Trial Register), NL8846. Registered 25 August 2020, https://trialsearch.who.int/Trial2.aspx?TrialID=NL8846.